Form 483

SterRx, LLC Form 483, 2023-06-28

FDA issued a Form 483 to SterRx, LLC on 2023-06-28 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

SterRx, LLC · Plattsburgh, United States · Issued June 28, 2023

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Jun 2023
21 CFR 211.194(a)(8)

Second person sign off

Cited by Edmund F Mrak, Pushpa S Jayasekara

28 Jun 2023
21 CFR 211.28(a)

Protective Apparel Not Worn

Cited by Edmund F Mrak, Pushpa S Jayasekara

28 Jun 2023
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Edmund F Mrak, Pushpa S Jayasekara

28 Jun 2023
21 CFR 211.63

Equipment Design, Size and Location

Cited by Edmund F Mrak, Pushpa S Jayasekara

28 Jun 2023
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Edmund F Mrak, Pushpa S Jayasekara

Inspected site

SLSterRx, LLCPlattsburgh, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere